+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The kinetic characterization of S-mephenytoin 4-hydroxylase activity in human liver samples obtained as surgical waste from Japanese patients



The kinetic characterization of S-mephenytoin 4-hydroxylase activity in human liver samples obtained as surgical waste from Japanese patients



Drug Metabolism & Disposition 21(4): 747-749




(PDF emailed within 1 workday: $29.90)

Accession: 033856029

Download citation: RISBibTeXText


Related references

The kinetic characterization of S-mephenytoin 4-hydroxylase (P-450IICMP) activity in human liver samples obtained as surgical waste from Japanese patients. Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(4): 747-749, 1993

Characterization and inhibition of mephenytoin 4-hydroxylase activity in human liver microsomes. Journal of Pharmacology and Experimental Therapeutics 240(1): 216-222, 1987

The role of S-mephenytoin 4'-hydroxylase in imipramine metabolism by human liver microsomes: a two-enzyme kinetic analysis of N-demethylation and 2-hydroxylation. British Journal of Clinical Pharmacology 37(3): 237-242, 1994

Mephenytoin hydroxylase activity in human liver: inhibition by steroids. Drug Metabolism and Disposition: the Biological Fate of Chemicals 13(6): 746-749, 1985

A convenient assay for mephenytoin 4-hydroxylase activity of human liver microsomal cytochrome P-450. Analytical Biochemistry 147(1): 174-179, 1985

Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase. Biochemistry 27(18): 6929-6940, 1988

Polymorphism in stereoselective hydroxylations of mephenytoin and hexobarbital by Japanese liver samples in relation to cytochrome P-450 human-2 (IIC9). Xenobiotica; the Fate of Foreign Compounds in Biological Systems 22(9-10): 1083-1092, 1992

Development and preliminary application of a simple assay of S-mephenytoin 4-hydroxylase activity in human liver microsomes. European Journal Of Clinical Pharmacology. 44(6): 559-562, 1993

The effects of selective serotonin reuptake inhibitors and their metabolites on S-mephenytoin 4'-hydroxylase activity in human liver microsomes. British Journal of Clinical Pharmacology 40(5): 481-485, 1995

Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes. Molecular Pharmacology 40(1): 69-79, 1991

Mephenytoin-type polymorphism of drug oxidation: purification and characterization of a human liver cytochrome P-450 isozyme catalyzing microsomal mephenytoin hydroxylation. Biochimica et Biophysica Acta 884(3): 435-447, 1986

Human liver microsomal cytochrome p 450 mephenytoin 4 hydroxylase a prototype of genetic polymorphism in oxidative drug metabolism purification and characterization of two similar forms involved in the reaction. Journal of Biological Chemistry 261(2): 909-921, 1986

Alterations in human CYP2C19, the major S-mephenytoin 4-hydroxylase, in poor metabolizers of S-mephenytoin. FASEB Journal 8(7): A1257, 1994

Human liver mephenytoin 4'-hydroxylase cytochrome P-450 proteins and genes. Drug Metabolism Reviews 20(2-4): 449-465, 1989

Characterization of phytanoyl-coenzyme A hydroxylase in human liver and activity measurements in patients with peroxisomal disorders. Clinica Chimica Acta. 271(2): 203-211, Ch 23, 1998